Laurus Labs Limited — Important, 06-12-2024: General Updates

The Board has approved an investment of INR 400 crore in Laurus Bio Private Limited, a subsidiary, while also finalizing agreements with Eight Roads Ventures and F-Prime Capital for their combined investment of INR 1,200 crore. The Investor funds are expected to be completed by the end of December 2024, while Laurus Labs’ investment will be concluded by June 30, 2025. Following these transactions, Laurus Labs will maintain a 74.64% stake, while the Investors will hold 13.73% on a fully diluted basis.

Laurus Bio is positioned in the biological products manufacturing sector and reported a turnover of INR 164.2 crore for the year ended March 31, 2024. This strategic investment aims to enhance Laurus Bio's capabilities and growth trajectory, presenting a positive outlook for future operations.